John Hurrell Ph.D. Email and Phone Number
John Hurrell Ph.D. work email
- Valid
- Valid
- Valid
John Hurrell Ph.D. personal email
- Valid
John Hurrell Ph.D. phone numbers
An executive leader with a strong track record of success in starting, building, growing and improving the profitability, performance and value of life science and diagnostics companies. I am recognized for developing, rescuing and launching products that have generated in excess of $5+ billion in revenues over a 20+year period, including products that required FDA and other national and regional/local regulatory approvals. My skills are in strategy development to leverage organizational resources/strengths, people, capital, technology identification and development, product/service offering, competitive positioning and global delivery, to drive revenues, profit and performance effectiveness. I am effective in high-profile executive roles, managing large and diverse organizations, growing business's at both the top and bottom lines, managing a global P&L in excess of $175Million, making tough decisions and overcoming complex business challenges. Experience includes research and development, product strategy and commercialization, market development, business/licensing/partnering negotiations and sales force development .I have a strong track record of building and managing global companies in the diagnostics industry.Specialties: •Vision, Strategy, Execution & Leadership •Product Research, Development & Launch•Strategic Business Planning & Direction•Technology/IP Investment & Commercialization•Company Growth in USA, Europe, Canada, Australia, S.E. Asia and Brazil markets•Managing complex global distributor network •Partnerships, Joint Ventures & Spin-Offs •Company Start-up, Turnaround, Reorganization & Growth •Licensing Agreement and other Business Negotiations•Profit & Loss Performance Enhancement•Global Organizational optimization
-
Non Executive Director And ConsultantBcal Diagnostics Apr 2024 - Present -
Chief Executive OfficerBcal Diagnostics Feb 2022 - Apr 2024BCAL is developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost effective, accurate and available to all women regardless of age, race and geographic location. Breast cancer is the most common cancer amongst women, therefore, improving the effectiveness of the screening and diagnosis technology used is a high priority. -
Chief Commercial OfficerJana Care Jul 2019 - Feb 2022Boston, Massachusetts, UsJanaCare is a company, headquartered in Boston with operations in Bangalore, India, and Singapore, utilizing smart phone and tablet technology in diagnostic applications to provide a mobile platform for results management and provide customized digital coaching programs to improve healthcare accessibility and quality -
AdvisorBaebies Jan 2018 - Jan 2019The Baebies mission is to save lives and make lives better for millions of children by bringing new technologies, new tests and new hope to parents and healthcare professionals worldwide. Baebies develops and delivers products and services based on digital microfluidics and other technology to advance newborn screening and pediatric testing worldwide
-
Non Executive ChairmanPts Diagnostics India Pvt.Ltd Jul 2016 - Nov 2018PTS Diagnostics India Pvt. Ltd. is a newly established subsidiary of PTS Diagnostics Inc which was recently acquired by Sinocare Inc., a publicly traded company headquartered in Changsha China. PTS Diagnostics India was established in order to sell the PTS Diagnostics products for cardiometabolic disorder monitoring directly into the India market.
-
Non Executive ChairmanAnteo Diagnostics Nov 2016 - Apr 2018Eight Mile Plains, Queensland, AuAnteo Diagnostics is a publicly traded (ASX: ADO) life science tools company located in Brisbane which had a subsidiary DIAsource in Louvain-La-Neuve, Belgium. Anteo Diagnostics specializes in the development and commercialization of proprietary surface coatings for applications in the Diagnostics, Energy (Li-ion batteries) and Medical Device sectors. In September 2017 the DIAsource subsidiary was sold and the Group CEO of Anteo resigned to continue with the divested company. I assumed the role of interim Executive Chairman to complete the divestiture , develop a modified strategy for company and lead the search for a new CEO. The new CEO commenced on January 1 2018 and I commenced the search for my replacement on the Board. -
Non Executive DirectorAnteo Diagnostics Mar 2013 - Apr 2018Eight Mile Plains, Queensland, AuAnteo Diagnostics is a publicly trade (ASX) life science tools company located in Brisbane with a corporate office in Sydney. Anteo Diagnostics specializes in the development and commercialization of proprietary surface coatings for applications in the diagnostics and biotech industries. -
President, Asia/Pacific RegionPts Diagnostics Sep 2015 - Jan 2018Whitestown, Indiana, UsResponsible for all PTS Diagnostics business in the Asia/Pacific Region and for the establishment of a direct sales subsidiary in Bangalore India.. -
Senior Vice President. International SalesPts Diagnostics Apr 2014 - Sep 2016Whitestown, Indiana, UsResponsible for the International sales of our Cardiochek lipid screening, PTS Detect and PTS Connect products outside of North America. -
Non Executive DirectorDiasource Immunoassays Apr 2016 - Sep 2017Louvain-La-Neuve, Brabant Wallon, BeDIAsource ImmunoAssays is an international diagnostic company, based in Belgium, that develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The company supplies a wide range of Vitamin D assays and reagents, including IVD and RUO Products. The panel of assays allows the detection and measurement of various forms of Vitamin D metabolites: 25OH Vitamin D, 1,25 (OH)2 Vitamin D. DIAsource is one of the leading manufacturers of Vitamin D radioimmunoassays The company has a direct sales subsidiary in Spain and sells through a network of distributors into more than 80 countries.Resigned as Non Executive Director at the completion of the sale of DIAsouce to BioVendor, a Czech based distributor of IVD and other clinical and life sciences products, -
Strategic Advisor And Board MemberJre Nov 2013 - Sep 2015
-
Non Executive DirectorFitgenes Pty Ltd Dec 2013 - Dec 2014Brisbane, Qld, AuFitgenes is an Australian organization pioneering a new genre of nutrigenetic and nutrigenomic education and clinical practice for health care Practitioners, through the integration of personalized genetic profiling, nutrition and exercise physiology, to create personalized health and wellness programs -
Senior Executive Vice PresidentSeegene Inc. Jan 2013 - Dec 2013서울, KrSeegene is a Molecular Diagnostics company based in Seoul, South Korea. It has strong IP and products which provide high level multiplex testing at relatively low cost. Main focus was infectious testing with oncology applications in clinical studies. It is the second largest focused life sciences company in South Korea. My responsibility was for the International Business Division including sales, support, clinical studies and business development including M&A, licensing and partnering. My territory was all regions outside of Korea. -
President And General Manager, Focus DiagnosticsQuest Diagnostics Inc Feb 2007 - Sep 2012Secaucus, Nj, UsGeneral Manager of an Infectious Disease focused business acquired by Quest Diagnostics. Company has 3 business segments, esoteric infectious disease reference laboratory, Clinical Trials testing and diagnostics products for infectious disease testing. Responsible for Enterix Pty Ltd, a FOB subsidiary of Quest located in Sydney Australia and NJ. Built a highly successful and profitable Molecular Diagnostics products business to more than $30million and growing in annual revenue in three years. Opened offices in Dublin and Singapore. Products launched in US, Europe, Asia/Pacific and Latin America -
Vp, Business Development, Office Of The Chairman And CeoQuest Diagnostics Inc Oct 2006 - Feb 2007Secaucus, Nj, UsI was involved with the acquisition of companies, businesses and technology for Quest Diagnostics -
President And General ManagerQuest Diagnostics Inc Jan 2006 - Oct 2006Secaucus, Nj, UsNID was a subsidiary of Quest Diagnostics with 350 staff worldwide in offices in San Clemente, Germany, France and staff in 6 other European countries. -
PresidentInproteo Llc Jul 2002 - Sep 2005Senior Executive of a synergistic partnership between Elli Lilly & Company with Indiana University/Purdue University to leverage the combined expertise of commercial drug discovery/development with world-class analytical chemistry; the consortium has a vision to develop innovative tools and technologies for proteomic research that will be commercialized via the spin-off of new companies, and JVs and partnerships.
-
Snr Vp And Gm Tripath Oncology (Interim Position)Tripath Imaging Inc Jan 2002 - Jul 2002
-
Executive Vp And CooArgose Inc Jul 2000 - Dec 2001Argose was a start up involved with development of non invasive glucose monitoring
-
President And CeoFluorrx Inc Jan 1997 - Jun 2000Founder and CEO of a start up based on fluorescence lifetime technology.
-
ConsultantQuantech 1996 - 1998
-
Vp Diagnostic TechnologiesGenzyme Inc Jan 1995 - Dec 1996
-
Snr Vp R&D OperationsBoehringer Mannheim 1989 - 1994
-
Global Technical DirectorMerck Serono 1988 - 1989Darmstadt, Hessen, De -
Vp R&DAdi Diagnostics 1984 - 1988
-
Head Immunochemistry R&DCsl 1980 - 1983
John Hurrell Ph.D. Skills
John Hurrell Ph.D. Education Details
-
Harvard Medical SchoolMonoclonal Antibody Technologies -
University Of MelbourneBiochemistry/Immunology -
University Of MelbourneBiochemistry/Chemistry -
University Of MelbourneBiochemistry And Molecular Biology
Frequently Asked Questions about John Hurrell Ph.D.
What company does John Hurrell Ph.D. work for?
John Hurrell Ph.D. works for Bcal Diagnostics
What is John Hurrell Ph.D.'s role at the current company?
John Hurrell Ph.D.'s current role is Non Executive Director and Consultant, BCAL Diagnostics.
What is John Hurrell Ph.D.'s email address?
John Hurrell Ph.D.'s email address is jh****@****are.com
What is John Hurrell Ph.D.'s direct phone number?
John Hurrell Ph.D.'s direct phone number is +131787*****
What schools did John Hurrell Ph.D. attend?
John Hurrell Ph.D. attended Harvard Medical School, University Of Melbourne, University Of Melbourne, University Of Melbourne.
What are some of John Hurrell Ph.D.'s interests?
John Hurrell Ph.D. has interest in Product Introduction Into New Markets, New Technology Commercialization.
What skills is John Hurrell Ph.D. known for?
John Hurrell Ph.D. has skills like Product Launch, Business Development, Strategic Partnerships, Infectious Diseases, Hardware Diagnostics, R&d, Product Development, Pharmaceutical Industry, Start Ups, Fda, Oncology, Management.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial